169 related articles for article (PubMed ID: 31323989)
41. Selenium effects on the metabolism of a Se-metabolizing Lactobacillus reuteri: analysis of envelope-enriched and extracellular proteomes.
Mangiapane E; Lamberti C; Pessione A; Galano E; Amoresano A; Pessione E
Mol Biosyst; 2014 Jun; 10(6):1272-80. PubMed ID: 24481235
[TBL] [Abstract][Full Text] [Related]
42. Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin.
Khmaladze I; Butler É; Fabre S; Gillbro JM
Exp Dermatol; 2019 Jul; 28(7):822-828. PubMed ID: 31021014
[TBL] [Abstract][Full Text] [Related]
43. FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri.
Thomas CM; Saulnier DM; Spinler JK; Hemarajata P; Gao C; Jones SE; Grimm A; Balderas MA; Burstein MD; Morra C; Roeth D; Kalkum M; Versalovic J
Microbiologyopen; 2016 Oct; 5(5):802-818. PubMed ID: 27353144
[TBL] [Abstract][Full Text] [Related]
44. The characteristics of lactic acid bacteria isolated from fermented food as potential probiotics.
Fitriani VY; Suprapti B; Amin M
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):743-749. PubMed ID: 34214350
[TBL] [Abstract][Full Text] [Related]
45. Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial.
Mangalat N; Liu Y; Fatheree NY; Ferris MJ; Van Arsdall MR; Chen Z; Rahbar MH; Gleason WA; Norori J; Tran DQ; Rhoads JM
PLoS One; 2012; 7(9):e43910. PubMed ID: 22970150
[TBL] [Abstract][Full Text] [Related]
46. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA
Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106
[TBL] [Abstract][Full Text] [Related]
47. Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis.
Geraldo BMC; Batalha MN; Milhan NVM; Rossoni RD; Scorzoni L; Anbinder AL
J Periodontal Res; 2020 Apr; 55(2):215-220. PubMed ID: 31691977
[TBL] [Abstract][Full Text] [Related]
48. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
49. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.
Peran L; Sierra S; Comalada M; Lara-Villoslada F; Bailón E; Nieto A; Concha A; Olivares M; Zarzuelo A; Xaus J; Gálvez J
Br J Nutr; 2007 Jan; 97(1):96-103. PubMed ID: 17217564
[TBL] [Abstract][Full Text] [Related]
50.
García Contreras AA; Vásquez Garibay EM; Sánchez Ramírez CA; Fafutis Morris M; Delgado Rizo V
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998471
[TBL] [Abstract][Full Text] [Related]
51. Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial.
Oncel MY; Sari FN; Arayici S; Guzoglu N; Erdeve O; Uras N; Oguz SS; Dilmen U
Arch Dis Child Fetal Neonatal Ed; 2014 Mar; 99(2):F110-5. PubMed ID: 24309022
[TBL] [Abstract][Full Text] [Related]
52. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G608-17. PubMed ID: 22207578
[TBL] [Abstract][Full Text] [Related]
53. Effect of Formula Containing Lactobacillus reuteri DSM 17938 on Fecal Microbiota of Infants Born by Cesarean-Section.
Garcia Rodenas CL; Lepage M; Ngom-Bru C; Fotiou A; Papagaroufalis K; Berger B
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):681-687. PubMed ID: 27035371
[TBL] [Abstract][Full Text] [Related]
54. Probiotics for infantile colic: a systematic review.
Anabrees J; Indrio F; Paes B; AlFaleh K
BMC Pediatr; 2013 Nov; 13():186. PubMed ID: 24238101
[TBL] [Abstract][Full Text] [Related]
55. In vitro selection and transferability of antibiotic resistance in the probiotic strain Lactobacillus reuteri DSM 17938.
Drago L; Rodighiero V; Mattina R; Toscano M; DE Vecchi E
J Chemother; 2011 Dec; 23(6):371-3. PubMed ID: 22233824
[No Abstract] [Full Text] [Related]
56. Proteomic analysis of the effect of bile salts on the intestinal and probiotic bacterium Lactobacillus reuteri.
Lee K; Lee HG; Choi YJ
J Biotechnol; 2008 Oct; 137(1-4):14-9. PubMed ID: 18680767
[TBL] [Abstract][Full Text] [Related]
57. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938.
Chau K; Lau E; Greenberg S; Jacobson S; Yazdani-Brojeni P; Verma N; Koren G
J Pediatr; 2015 Jan; 166(1):74-8. PubMed ID: 25444531
[TBL] [Abstract][Full Text] [Related]
58. Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations.
Juárez Tomás MS; De Gregorio PR; Leccese Terraf MC; Nader-Macías ME
Eur J Pharm Sci; 2015 Nov; 79():87-95. PubMed ID: 26299342
[TBL] [Abstract][Full Text] [Related]
59. Safety and efficacy of human breast milk Lactobacillus fermentum CECT 5716. A mini-review of studies with infant formulae.
López-Huertas E
Benef Microbes; 2015; 6(2):219-24. PubMed ID: 25519525
[TBL] [Abstract][Full Text] [Related]
60. Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial.
Yang C; Liang L; Lv P; Liu L; Wang S; Wang Z; Chen Y
Helicobacter; 2021 Dec; 26(6):e12856. PubMed ID: 34628695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
